Pharma Journalist -

Amneal Pharmaceuticals, Inc. and AvKARE Inc. announced they have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related…
Read More...

Flagship Pioneering, a unique life sciences innovation enterprise, unveiled Cellarity, a first-of-its-kind therapeutics company that is discovering and developing medicines by studying…
Read More...

Dermira, a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with…
Read More...

UK-based biotechnology company Retrogenix and US-based Resonant Therapeutics, Inc. announced that they have entered into a non-exclusive strategic partnership to identify the targets of…
Read More...

Bloom Science, a biopharmaceutical company developing microbiome-derived therapeutics in multiple neurological conditions and oncology, announced the launch of a research agreement with…
Read More...

LEO Pharma A/S announced that tralokinumab – an investigational, fully human monoclonal antibody that specifically neutralizes the interleukin-13 (IL-13) cytokine – met all primary and…
Read More...

AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration…
Read More...

Merck, known as MSD outside the United States and Canada, and ArQule, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary,…
Read More...

Healx Ltd., the AI-powered biotechnology company focused on developing breakthrough treatments for rare diseases, announces it has entered into an agreement with Boehringer Ingelheim to…
Read More...

Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a…
Read More...